What is the main business of Noblepharma Bis?

The main business activity of Noblepharma Bis focuses on manufacture of homogenised food preparations and dietetic food.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on January 14, 2020.

Where is the headquarters located?

The headquarters is located at: ul. Świerkowa 12, 05-850 Piotrkówek Duży.

Who is on the management board?

The management board consists of: Gerard Artur Krawczyk (Member of the Management Board) and Sylwia Katarzyna Bełdycka (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

In 2024, the company generated total revenue of $59,588, representing a decrease of 99.2% compared to 2023.

No, in 2024 the company was not profitable, reporting a net loss of $12,139.

What is the largest operating cost?

The largest operating cost category falls under materials and energy. This category amounted to $46,280 in 2024, representing 65% of all operating expenses.

Noblepharma Bissp. z o.o.

Manufacture of homogenised food preparations and dietetic food

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2020-01-14

Share capital

5 000,00 PLN

Activity description

Noblepharma Bis is a company that offers a variety of dietary supplements, including vitamins, collagen products, and medical foods used in orthomolecular medicine. They also provide enzymatic therapies and specialize in products for beauty, joints, and tendons. Their offerings are utilized in orthomolecular therapy and enzymotherapy.

Registered address

ul. Świerkowa 12, 05-850 Piotrkówek Duży, Poland

Website

noblepharma.pl

Phone

Social media

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 0.19MedianUSD 426.41kAverageUSD 6.29m

Net profit

This companyUSD -18.06kMedianUSD 7.02kAverageUSD 456.45k

Operating costs

This companyUSD 18.05kMedianUSD 402.63kAverageUSD 5.58m

Assets

This companyUSD 858.18kMedianUSD 378.64kAverageUSD 5.67m

Industry

Bank accounts

Registered as a VAT taxpayer on 2020-10-31. Active

mBank
25 1140 1108 0000 3061 8100 1001
mBank
68 1140 1108 0000 3061 8100 1003
mBank
95 1140 1108 0000 3061 8100 1002

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Gerard Artur Krawczyk – Management Board Member

Sylwia Katarzyna Bełdycka – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Sylwia Katarzyna Bełdycka (46)	50	$675.31	50%
Gerard Artur Krawczyk (51)	50	$675.31	50%

Beneficial owners

Person	Rights

Competitors

	Name	Revenue	Website
	Taorasp. z o.o.	$0.08	taora.pl

Change history

Date	Event
2025-04-22	Address change (Ul. Bruzdowa 20b, 02-994, Warszawa → Ul. Świerkowa 12, 05-850, Piotrkówek Duży)
2025-04-22	PKD change (Added: 10.86.Z, 10.89.A, 46.17.Z, 46.32.Z, 46.38.Z, 46.46.Z, 47.11.Z, 47.91.Z)
2023-09-21	Address change (Ul. Wawelska 5, 02-034, Warszawa → Ul. Bruzdowa 20b, 02-994, Warszawa)
2020-01-14	Entered in the register

FAQ

Last updated: 2026-07-09